Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Blood stem cells develop through different stages to become fully mature red blood cells. This fundamental biologic process ...

In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...